BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

895 related articles for article (PubMed ID: 25465936)

  • 1. Impact of atrial fibrillation on outcomes in patients who underwent transcatheter aortic valve replacement.
    Maan A; Heist EK; Passeri J; Inglessis I; Baker J; Ptaszek L; Vlahakes G; Ruskin JN; Palacios I; Sundt T; Mansour M
    Am J Cardiol; 2015 Jan; 115(2):220-6. PubMed ID: 25465936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and Impact of Atrial Fibrillation in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: An Analysis From the SOURCE XT Prospective Multicenter Registry.
    Tarantini G; Mojoli M; Windecker S; Wendler O; Lefèvre T; Saia F; Walther T; Rubino P; Bartorelli AL; Napodano M; D'Onofrio A; Gerosa G; Iliceto S; Vahanian A
    JACC Cardiovasc Interv; 2016 May; 9(9):937-46. PubMed ID: 27085579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial fibrillation, stroke, and mortality rates after transcatheter aortic valve implantation.
    Yankelson L; Steinvil A; Gershovitz L; Leshem-Rubinow E; Furer A; Viskin S; Keren G; Banai S; Finkelstein A
    Am J Cardiol; 2014 Dec; 114(12):1861-6. PubMed ID: 25438914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal changes of new-onset atrial fibrillation in patients randomized to surgical or transcatheter aortic valve replacement.
    Jørgensen TH; Thyregod HG; Tarp JB; Svendsen JH; Søndergaard L
    Int J Cardiol; 2017 May; 234():16-21. PubMed ID: 28258844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of cardiovascular mortality, bleeding, vascular and cerebrovascular events in patients with atrial fibrillation vs. sinus rhythm undergoing transfemoral Transcatheter Aortic Valve Implantation (TAVR).
    Herold J; Herold-Vlanti V; Sherif M; Luani B; Breyer C; Bonaventura K; Braun-Dullaeus R
    BMC Cardiovasc Disord; 2017 Dec; 17(1):298. PubMed ID: 29262768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk stratification and clinical pathways to optimize length of stay after transcatheter aortic valve replacement.
    Lauck SB; Wood DA; Achtem L; Baumbusch J; Boone RH; Cheung A; Dvir D; Stub D; Tan JS; Ye J; Webb JG
    Can J Cardiol; 2014 Dec; 30(12):1583-7. PubMed ID: 25475463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New-onset atrial fibrillation after aortic valve replacement: comparison of transfemoral, transapical, transaortic, and surgical approaches.
    Tanawuttiwat T; O'Neill BP; Cohen MG; Chinthakanan O; Heldman AW; Martinez CA; Alfonso CE; Mitrani RD; Macon CJ; Carrillo RG; Williams DB; O'Neill WW; Myerburg RJ
    J Am Coll Cardiol; 2014 Apr; 63(15):1510-9. PubMed ID: 24486264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of varying degrees of renal dysfunction on transcatheter and surgical aortic valve replacement.
    Nguyen TC; Babaliaros VC; Razavi SA; Kilgo PD; Guyton RA; Devireddy CM; Shults CC; Mavromatis K; Kanitkar M; Block P; Lerakis S; Thourani VH
    J Thorac Cardiovasc Surg; 2013 Dec; 146(6):1399-406; discussion 13406-7. PubMed ID: 24075566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence, Predictive Factors, and Effect of Delirium After Transcatheter Aortic Valve Replacement.
    Abawi M; Nijhoff F; Agostoni P; Emmelot-Vonk MH; de Vries R; Doevendans PA; Stella PR
    JACC Cardiovasc Interv; 2016 Jan; 9(2):160-8. PubMed ID: 26793958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of pulmonary artery systolic pressure in patients undergoing transcatheter aortic valve replacement for aortic stenosis.
    Bishu K; Suri RM; Nkomo VT; Kane GC; Greason KL; Reeder GS; Mathew V; Holmes DR; Rihal CS; Melduni RM
    Am J Cardiol; 2014 Nov; 114(10):1562-7. PubMed ID: 25260946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Atrial Fibrillation and Atrial Flutter by Pacemaker Device Interrogation After Transcatheter Aortic Valve Replacement (TAVR): Implications for Management.
    Megaly M; Garcia S; Anzia LE; Morley P; Garberich R; Gornick CC; Lesser J; Sorajja P; Gössl M; Sengupta J
    J Invasive Cardiol; 2019 Jul; 31(7):E177-E183. PubMed ID: 31257211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of and Prognostic Significance of Atrial Fibrillation in Patients Undergoing Transcatheter Aortic Valve Implantation.
    Sannino A; Stoler RC; Lima B; Szerlip M; Henry AC; Vallabhan R; Kowal RC; Brown DL; Mack MJ; Grayburn PA
    Am J Cardiol; 2016 Nov; 118(10):1527-1532. PubMed ID: 27666171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence, predictive factors, and prognostic value of new-onset atrial fibrillation following transcatheter aortic valve implantation.
    Amat-Santos IJ; Rodés-Cabau J; Urena M; DeLarochellière R; Doyle D; Bagur R; Villeneuve J; Côté M; Nombela-Franco L; Philippon F; Pibarot P; Dumont E
    J Am Coll Cardiol; 2012 Jan; 59(2):178-88. PubMed ID: 22177537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propensity-matched comparisons of clinical outcomes after transapical or transfemoral transcatheter aortic valve replacement: a placement of aortic transcatheter valves (PARTNER)-I trial substudy.
    Blackstone EH; Suri RM; Rajeswaran J; Babaliaros V; Douglas PS; Fearon WF; Miller DC; Hahn RT; Kapadia S; Kirtane AJ; Kodali SK; Mack M; Szeto WY; Thourani VH; Tuzcu EM; Williams MR; Akin JJ; Leon MB; Svensson LG
    Circulation; 2015 Jun; 131(22):1989-2000. PubMed ID: 25832034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Pre-Existing and New-Onset Atrial Fibrillation on Outcomes After Transcatheter Aortic Valve Replacement.
    Mentias A; Saad M; Girotra S; Desai M; Elbadawi A; Briasoulis A; Alvarez P; Alqasrawi M; Giudici M; Panaich S; Horwitz PA; Jneid H; Kapadia S; Vaughan Sarrazin M
    JACC Cardiovasc Interv; 2019 Nov; 12(21):2119-2129. PubMed ID: 31629743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. General Anesthesia Increased the Risk of Atrial Fibrillation and Acute Kidney Injury in Transcatheter Aortic Valve Replacement.
    Liang Y; Wang W; Wang X; Liu M; Hei F; Guan Y
    Heart Surg Forum; 2021 Feb; 24(1):E082-E100. PubMed ID: 33635259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (cohort A).
    Elmariah S; Palacios IF; McAndrew T; Hueter I; Inglessis I; Baker JN; Kodali S; Leon MB; Svensson L; Pibarot P; Douglas PS; Fearon WF; Kirtane AJ; Maniar HS; Passeri JJ;
    Circ Cardiovasc Interv; 2013 Dec; 6(6):604-14. PubMed ID: 24221391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex-related differences in outcomes after transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis: Insights from the PARTNER Trial (Placement of Aortic Transcatheter Valve).
    Williams M; Kodali SK; Hahn RT; Humphries KH; Nkomo VT; Cohen DJ; Douglas PS; Mack M; McAndrew TC; Svensson L; Thourani VH; Tuzcu EM; Weissman NJ; Kirtane AJ; Leon MB
    J Am Coll Cardiol; 2014 Apr; 63(15):1522-8. PubMed ID: 24561149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors and clinical implications of atrial fibrillation in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation.
    Barbash IM; Minha S; Ben-Dor I; Dvir D; Torguson R; Aly M; Bond E; Satler LF; Pichard AD; Waksman R
    Catheter Cardiovasc Interv; 2015 Feb; 85(3):468-77. PubMed ID: 25323129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Incidence and Predictors of Early- and Mid-Term Clinically Relevant Neurological Events After Transcatheter Aortic Valve Replacement in Real-World Patients.
    Bosmans J; Bleiziffer S; Gerckens U; Wenaweser P; Brecker S; Tamburino C; Linke A;
    J Am Coll Cardiol; 2015 Jul; 66(3):209-217. PubMed ID: 26184612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.